Koninklijke Philips (PHG) Income from Non-Controlling Interests (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Income from Non-Controlling Interests came in at -$5.9 million in Q1 2026, down 39.12% year-on-year from -$9.6 million in Q1 2025, and down 351.44% quarter-over-quarter from $2.3 million in Q4 2025.

Koninklijke Philips (PHG) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends

Koninklijke Philips' Income from Non-Controlling Interests history runs 18 years deep, the most recent figure standing at -$5.9 million for Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests fell 39.12% year-over-year to -$5.9 million in Q1 2026; TTM through Mar 2026 was -$3.6 million, a 179.22% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 63.69% from the prior year.
  • Income from Non-Controlling Interests slipped to -$5.9 million in Q1 2026 per PHG's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $4.4 million in Q3 2023 and bottomed at -$5.9 million in Q1 2026.
  • The 5-year median for Income from Non-Controlling Interests is $2.2 million (2024), against an average of $751917.0.
  • Across the five-year window, Income from Non-Controlling Interests soared 43.95% in 2023 and slumped 153.23% in 2025, its largest moves.
  • Year by year, Income from Non-Controlling Interests stood at $3.0 million in 2022, then surged by 43.95% to $4.4 million in 2023, then sank by 49.56% to $2.2 million in 2024, then rose by 5.99% to $2.3 million in 2025, then slumped by 351.44% to -$5.9 million in 2026.
  • Per Business Quant, the three latest PHG Income from Non-Controlling Interests figures stand at -$5.9 million (Q1 2026), $2.3 million (Q4 2025), and -$1.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.90 Bn 176.61 Bn 6.27 Bn -
2 Stryker 128.85 Bn 125.97 Bn 3.81 Bn -
3 Medtronic 108.77 Bn 99.55 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 68.39 Bn 66.93 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.50 Bn 44.83 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.36 Bn 26.08 Bn 1.98 Bn 22.00 Mn
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn -
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 25.48 Bn 22.35 Bn 2.07 Bn -5.85 Mn
10 Steris 21.57 Bn 21.13 Bn 697.10 Mn 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.85 Mn
Dec 31, 2025 2.33 Mn
Sep 30, 2025 -1.17 Mn
Jun 30, 2025 1.13 Mn
Mar 31, 2025 -4.21 Mn
Sep 30, 2024 2.20 Mn
Jun 30, 2024 2.15 Mn
Sep 30, 2023 4.35 Mn
Jun 30, 2023 2.18 Mn
Sep 30, 2022 3.02 Mn
Jun 30, 2022 2.13 Mn
Dec 31, 2021 -6.86 Mn
Sep 30, 2021 8.26 Mn
Jun 30, 2021 2.41 Mn
Mar 31, 2021 1.21 Mn
Dec 31, 2020 4.77 Mn
Sep 30, 2020 2.34 Mn
Jun 30, 2020 2.20 Mn
Mar 31, 2020 1.10 Mn
Dec 31, 2019 -2.21 Mn